New diabetes pill tested in japanese volunteers – early safety results expected
NCT ID NCT06869018
First seen Oct 01, 2025 · Last updated Jun 10, 2026 · Updated 33 times
Summary
This early-stage study tested a new oral drug, LY3549492, in 92 Japanese adults—some with type 2 diabetes and some healthy. The main goal was to see if the drug is safe and what side effects it might cause. Researchers also measured how much drug gets into the blood and how the body processes it. The study lasted up to 25 weeks and is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Hospital Tokyo
Shinjuku-ku, 160-0004, Japan
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
Medical Corporation Heishinkai OPHAC Hospital
Osaka, 532-0003, Japan
-
P-One Clinic
Hachiōji, 192-0071, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.